3 news items
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer's Disease Patients
ATHA
12 Jun 24
statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
ATHA
15 Apr 24
to advance its product candidates into later stages of development. Forward-looking statements generally include statements that are predictive in nature
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease
ATHA
11 Apr 24
candidates into later stages of development. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer
- Prev
- 1
- Next